"Biosimilars differ from generics because they are complex molecules, large, made in cellular factories."
Dr. David Henry, Clinical Professor of Medicine and Vice Chairman of the Department of Medicine at Pennsylvania Hospital
Biological therapies are so complex to develop and purify that even the reference medicine differs slightly from one batch to the next. Biosimilars are held to the same high "clinically indistinguishable" standards of outcomes and purity as an approved subsequent batch of an original reference therapy.
2400 North Commerce Parkway,
Weston, Florida 33326